Dayton, N.J., October 22, 2015 – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. The Division of Bioequivalence has determined Aurobindo Pharma Limited’s Memantine Hydrochloride Tablets USP, 5 mg and 10 mg to be bioequivalent and, therefore, therapeutically equivalent […]

(Reuters Health) – Following a Mediterranean diet rich in fruits, vegetables, legumes, whole grains, fish and healthy fats may preserve a more youthful brain in old age, a U.S. study suggests. Previous research has connected a Mediterranean diet to a reduced risk of developing Alzheimer’s disease and other degenerative brain conditions, noted lead study author […]

Genetics company 23andMe announced the launch of a new consumer genetic test service on Wednesday that will show whether an individual carries genes associated with 36 different disorders, such as cystic fibrosis. The launch is a major step for the company, which in 2013 was ordered by the Food and Drug Administration to stop selling […]

Nestle, famous for its coffee and chocolate, is stepping up investment in nutritional therapy, a business it believes will eventually generate annual sales of 10 billion Swiss francs ($10.5 billion).   Greg Behar, chief executive of Nestle Health Science, told Reuters that the unit formed in 2011 already had revenue of more than 2 billion […]

Teva Pharmaceutical Industries Ltd’s research chief said on Tuesday the drug industry must act responsibly when it comes to pricing medications, given the mounting anger over the high cost of therapies in the United States.   Democratic presidential candidate Hillary Clinton brought new attention to the issue last week, proposing to cap patients’ treatment costs, […]

One in three people born in Britain in 2015 will develop dementia, according to an analysis commissioned by the charity campaign group Alzheimer’s Research UK. The study, conducted by the Office of Health Economics, shows “a looming national health crisis as the UK population ages”, the charity said, and underlines the need for global efforts […]

Intra-Cellular Therapies Inc said a higher dose of its lead drug was found to be effective in reducing the severity of schizophrenia symptoms in a late-stage study, sending its shares up more than 50 percent in premarket trading. Patients treated with 60 mg of the drug, ITI-007, showed improvement over placebo. The 40 mg dosage, […]

The U.S. Food and Drug Administration (FDA) advised Waltham, Mass.-based FORUM Pharmaceuticals to halt its clinical trials of encenicline for Alzheimer’s disease yesterday. The FDA cited a small number of serious gastrointestinal (GI) side effects in the studies. As a result, FORUM halted the trial, discontinuing the medication and no new patients will be recruited […]

(Reuters Health) – Older adults with low vitamin D levels – and that accounts for most of them – may lose their memories and thinking abilities faster than those with normal vitamin D levels, researchers say. “We were not particularly surprised by our findings because there is a recent and growing literature on the associations […]

Resveratrol Impacts Alzheimer’s Disease Biomarker The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer’s disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol. Resveratrol is a naturally occurring compound found in foods such as […]